Cohort study

Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation

J Am Coll CardiolPublished

  • Retrospective cohort study
  • multicentre (15 centers)
  • matched

Authors' conclusion

Higher FALD scores were associated with post-transplant mortality. Although prospective confirmation of our findings is necessary, compared with HT alone, CHLT recipients were older with higher FALD scores, but had similar survival overall and superior survival in patients with a FALD score ≥2.

Study context

Population
Adult Fontan patients (age ≥16 years at referral) referred for and undergoing HT or combined heart-liver transplant (CHLT)
Participants
131 patients
Exposure
Combined heart-liver transplant vs heart transplant alone
  • CHLTn = 40
  • HTn = 91reference

Main finding

As reported in the abstract

Post-transplant survival (matched)

1-year survival

P = 0.097

5-year survival

P = 0.041

Observational data: associations, not effects.

Further findings

Survival in patients with FALD score ≥2 (subgroup) · 5 years

P = 0.019

1-year survival

P = 0.044

5-year survival

OutcomeHRP value
Survival, model adjusted for transplant decade and FALD score — CHLT vs HT0.33P = 0.044
Survival, model adjusted for transplant decade and FALD score — FALD score 2 vs HT · worse survival14.6P = 0.015
Survival, model adjusted for transplant decade and FALD score — FALD score 3 vs HT · worse survival22.2P = 0.007
Survival, model adjusted for transplant decade and FALD score — FALD score 4 vs HT · worse survival27.8P = 0.011

Original publication

Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation. J Am Coll Cardiol. Published 6 June 2023. doi:10.1016/j.jacc.2023.03.421

Summarised from the published abstract; every number is checked against it